The genetic defect causing Huntington's disease (HD) has been identified as an unstable expansion of a trinucleotide (CAG) repeat sequence within the coding region of the IT15 gene on chromosome 4. In 50 patients with manifest HD who were evaluated prospectively and uniformly, we examined the relationship between the extent of the DNA expansion and the rate of illness progression. Although the length of CAG repeats showed a strong inverse correlation with the age at onset of HD, there was no such relationship between the number of CAG repeats and the rate of clinical decline. These findings suggest that the CAG repeat length may influence or trigger the onset of HD, but other genetic, neurobiological, or environmental factors contribute to the progression of illness and the underlying pace ofneuronal degeneration.
An unstable expansion of trinucleotide (CAG) repeats in the IT1 5 gene has been identified as the genetic defect underlying the inheritance ofHuntington's disease (HD) .' While the number of CAG repeats in IT1 5 ranges normally from nine to 37, the number of repeats in affected HD persons ranges from 37 to 102.2-7 A strong inverse correlation between the number of trinucleotide repeats and the age at onset of HD has been shown; however, no apparent relationship has been found between the number of repeats and clinical manifestations of illness. 48 Early age at onset of HD has been considered a harbinger of more rapid progression of 
Results
Of the 54 blood sami lysis produced reliabl patients, consisting of with a mean age of 50 15 to 77 years) at the ti of HD had been pre years (range 4 to 27), HD of 37-0 (SD The patients were en 6-3 (SD 3-6) differer 16) and were followed for 4-4 (SD 2 9) years (range 05 to . The TFC at initial evalu-99 ation was 9-2 (SD 2-1) (range 2 to 13), and 80 the TFC at final evaluation was 6 8 (SD 3 1)
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(range 0 to 12 strong relationship between CAG repeat length in the IT1 5 gene and the age at onset of HD. However, consistent with the report of Roos et al,9 we found no relationship between age at onset ofHD and severity ofillness. In a previous study we examined the rate of functional decline in a cohort of 129 prospectively evaluated patients with HD and, contrary to previous reports,'5 found no correlation between functional decline and age at onset, body weight, gender of affected parent, or neuroleptic use. 12 Our current study failed to establish any relationship between the number of CAG repeats and the rate of functional decline as assessed by the TFC scale. These findings suggest that the range of HD severity is relatively uniform across a large spectrum of age at onset and CAG repeat length. However, we found considerable variability in the rate of decline in our cohort, ranging from relatively stable illness to declining at greater than two TFC units per year (fig 2) . Taken together, these observations suggest that the number of CAG repeats is a strong predictor of the age at onset of HD but not of the pace of disease progression. Thus, the CAG repeat length may play an important role in the initiation of the {e (unitslyear) and CAG
The lack of association between the number of CAG repeats and the progression of illness limits the use of CAG repeat length as a reliable predictor of the clinical course. Some of our )les obtained, DNA ana-patients with relatively few repeat lengths exle CAG results from 50 perienced a rapid clinical decline while some f 24 men and 26 women patients with high repeat lengths had a relatively *9 (SD 14-3) years (range slow clinical course. These findings have imime ofsampling. Features plications for genetic counselling and the apsent for 13-8 (SD 5'5) propriate interpretation of genetic test results with a mean duration of in patients with symptomatic HD. These obi) years (range 7 to 63). servations may extend to asymptomatic persons valuated prospectively on at risk for HD, but need to be confirmed in it occasions (range 2 to such a population. 
